KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teladoc Health (TDOC) Raw Materials (2020 - 2023)

Teladoc Health's Raw Materials history spans 4 years, with the latest figure at $26.4 million for Q1 2023.

  • For Q1 2023, Raw Materials rose 5.59% year-over-year to $26.4 million; the TTM value through Mar 2023 reached $26.4 million, up 5.59%, while the annual FY2022 figure was $30.1 million, 5.56% up from the prior year.
  • Raw Materials for Q1 2023 was $26.4 million at Teladoc Health, down from $30.1 million in the prior quarter.
  • Across five years, Raw Materials topped out at $30.1 million in Q4 2022 and bottomed at $17.0 million in Q2 2022.
  • The 4-year median for Raw Materials is $23.9 million (2021), against an average of $23.8 million.
  • The largest annual shift saw Raw Materials skyrocketed 45.68% in 2021 before it dropped 25.39% in 2022.
  • A 4-year view of Raw Materials shows it stood at $19.6 million in 2020, then skyrocketed by 45.68% to $28.5 million in 2021, then rose by 5.56% to $30.1 million in 2022, then fell by 12.36% to $26.4 million in 2023.
  • Per Business Quant, the three most recent readings for TDOC's Raw Materials are $26.4 million (Q1 2023), $30.1 million (Q4 2022), and $27.6 million (Q3 2022).